Literature DB >> 7993804

Red cell lipid abnormalities in acquired acanthocytosis are extended to platelets.

C Ulibarrena1, A Vecino, J M Cesar.   

Abstract

Acquired acanthocytosis (AA) is an uncommon disease characterized by the presence of abnormal red cells (acanthocytes) in the blood smears of affected subjects. Acanthocyte membrane is enriched in cholesterol by an abnormal plasma lipoprotein. We studied the existence of similar changes in platelets of one patient with AA. Red cell cholesterol/phospholipid (Ch/PL) ratio in the patient was 1.6 (normal 1.1 +/- 0.1). Phosphatidylcholine (PC) comprised 36% of total phospholipid (30.7 +/- 1.8% in controls). Platelets showed aberrant morphology in the blood smears, and the ratio Ch/PL was high in comparison with normal platelets (1.4 v 0.6 +/- 0.1). PC comprised 52% of total PL (39.6 +/- 1.9% in normal platelets). Normal platelets incubated with autologous plasma for 24 h maintained a Ch/PL ratio of 0.7, whereas this value changed to 1.4 when these cells were incubated with plasma from the patient. These results suggest that platelets of patients affected by AA acquire the same biochemical abnormality as red cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7993804     DOI: 10.1111/j.1365-2141.1994.tb08322.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?

Authors:  Vinay Sundaram; Abdullah M S Al-Osaimi; Jason J Lewis; Ton Lisman; Stephen H Caldwell
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

2.  Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice.

Authors:  Vandana S Dole; Jana Matuskova; Eliza Vasile; Ayce Yesilaltay; Wolfgang Bergmeier; Michael Bernimoulin; Denisa D Wagner; Monty Krieger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-24       Impact factor: 8.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.